77 related articles for article (PubMed ID: 310195)
21. Preexistent anti-HLA-DR antibodies and kidney graft survival.
Sirchia G; Mercuriali F; Scalamogna M; Rosso di San Secondo V; Pizzi C; Poli F; Fortis C; Greppi N
Transplant Proc; 1979 Mar; 11(1):950-3. PubMed ID: 377727
[No Abstract] [Full Text] [Related]
22. DRw antigen matching and B-cell antibody crossmatching: their effect on clinical outcome of renal transplants.
Cross DE; Coxe-Gilliland R; Weaver P
Transplant Proc; 1979 Dec; 11(4):1908-10. PubMed ID: 394436
[TBL] [Abstract][Full Text] [Related]
23. HLA typing using IL-2 activated T lymphocytes: usefulness in pediatric candidates for allogeneic bone marrow transplantation.
Kubo K; Tachino J; Ichikawa S; Hamamoto K; Ueda K
Bone Marrow Transplant; 1991 Sep; 8(3):185-90. PubMed ID: 1720338
[TBL] [Abstract][Full Text] [Related]
24. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
25. Specific anti-donor lymphocytotoxic antibodies following blood transfusion from nonrelated donors.
Ettenger RB; Jordan SC; Arnett J; Robinson BJ; Fine RN
Transplant Proc; 1982 Jun; 14(2):347-8. PubMed ID: 7051476
[No Abstract] [Full Text] [Related]
26. Immediate rejection of a HLA-A, B compatible, HLA-DR incompatible kidney with a positive donor-recipient B-cell crossmatch.
Berg B; Möller E
Scand J Urol Nephrol Suppl; 1980; 54():36. PubMed ID: 7013039
[No Abstract] [Full Text] [Related]
27. [New technic for purification of lymphocytes for HLA typing].
Mantovani V; Calanca F; Barboni P
Boll Soc Ital Biol Sper; 1989 Oct; 65(10):967-73. PubMed ID: 2624715
[TBL] [Abstract][Full Text] [Related]
28. Study of human T and B lymphocytes with heterologous antisera. I Preparation, specificity and properties of antisera.
Brochier J; Abou-Hamed YA; Gueho JP; Revillard JP
Immunology; 1976 Nov; 31(5):749-58. PubMed ID: 1086826
[TBL] [Abstract][Full Text] [Related]
29. [Italian "pre-workshop" for the study of B-lymphocyte membrane antigens].
Belvedere M; Diotallevi P; Richiardi P
Riv Emoter Immunoematol; 1977; 24(3-4):116-27. PubMed ID: 305096
[No Abstract] [Full Text] [Related]
30. HLA-DR typing by radioimmunoassay.
Tosi R; Tanigaki N; Centis D; Rossi PL; Alfano G; Ferrara GB; Pressman D
Transplantation; 1980 Apr; 29(4):302-5. PubMed ID: 7368279
[TBL] [Abstract][Full Text] [Related]
31. [Method of the lymphocytotoxicity test for HLA typing].
Araki N; Shimizu J; Nose Y
Nihon Rinsho; 1990 Feb; 48 Suppl():765-9. PubMed ID: 2355609
[No Abstract] [Full Text] [Related]
32. The positive B-cell cross-match: a marker of active enhancement?
d'Apice AJ; Tait BD
Transplant Proc; 1979 Mar; 11(1):954-7. PubMed ID: 377728
[No Abstract] [Full Text] [Related]
33. Effects of anti recirculating lymphocyte globulin and anti non-recirculating lymphocyte globulin on B-dependent and T-dependent lymphocytes in the rat.
Dionigi R; Zonta A; Dominioni L; Bellinzona G
Boll Ist Sieroter Milan; 1974; 53(2):355-60. PubMed ID: 4609443
[No Abstract] [Full Text] [Related]
34. [Is the fluorescence cytotoxicity test for the determination of HLA-DR antigens more sensitive than the classical microcytotoxicity test?].
Prazák J; Májský A
Cas Lek Cesk; 1989 Aug; 128(33):1047-9. PubMed ID: 2790911
[TBL] [Abstract][Full Text] [Related]
35. Production in vitro of antibodies directed against alloantigen-specific recognition sites on T cells and on lymphocytotoxic HLA antibodies.
Singal DP; Blajchman MA; Joseph S; Roberge B; Smith EK; Ludwin D
Clin Exp Immunol; 1988 May; 72(2):222-7. PubMed ID: 2970351
[TBL] [Abstract][Full Text] [Related]
36. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
Hohlfeld R; Conti-Tronconi B; Kalies I; Bertrams J; Toyka KV
J Immunol; 1985 Oct; 135(4):2393-9. PubMed ID: 2411794
[TBL] [Abstract][Full Text] [Related]
37. Sera from volunteers immunized by planned blood transfusions as source of DR cytotoxic typing reagents.
Belvedere M; Richiardi P; Curtoni ES; Pellegrino MA; Ferrone S
Immunol Commun; 1979; 8(1):93-106. PubMed ID: 311335
[TBL] [Abstract][Full Text] [Related]
38. Anti-HLA-DR alloantibodies eluted from human placental tissue.
Brochier J; Bonneau M; Robert M; Samarut C; Revillard JP; Traeger J
Transplant Proc; 1979 Mar; 11(1):779-82. PubMed ID: 156435
[No Abstract] [Full Text] [Related]
39. [Clinical significance of anti-lymphocyte antibody assay].
Sekiguchi S
Nihon Rinsho; 1990 Feb; 48 Suppl():620-3. PubMed ID: 2355585
[No Abstract] [Full Text] [Related]
40. Antisera to human B-lymphocyte membrane glycoproteins block stimulation in mixed lymphocyte culture.
Cresswell P; Geler SS
Nature; 1975 Sep; 257(5522):147-9. PubMed ID: 51476
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
